Ownership history in ORBIMED ADVISORS LLC · 9 quarters on record
This page tracks every 13F SEC filing in which ORBIMED ADVISORS LLC reported a position in STRUCTURE THERAPEUTICS INC (GPCR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 1,161,803 | +22,503 | +2.0% | 1.65% | $80.8M | $69.55 |
| 2025 Q3 | REDUCED | 1,139,300 | -60,000 | -5.0% | 0.75% | $31.9M | $28.00 |
| 2025 Q2 | ADDED | 1,199,300 | +547,272 | +83.9% | 0.62% | $24.9M | $20.74 |
| 2025 Q1 | ADDED | 652,028 | +502,028 | +334.7% | 0.27% | $11.3M | $17.31 |
| 2025 Q1 | REDUCED | 150,000 | -502,028 | -77.0% | 0.06% | $2.6M | $17.31 |
| 2024 Q4 | ADDED | 652,028 | +502,028 | +334.7% | 0.36% | $17.7M | $27.12 |
| 2024 Q4 | REDUCED | 150,000 | -233,705 | -60.9% | 0.08% | $4.1M | $27.12 |
| 2024 Q3 | ADDED | 383,705 | +258,705 | +207.0% | 0.31% | $16.8M | $43.89 |
| 2024 Q2 | INITIATED | 125,000 | — | — | 0.10% | $4.9M | — |
As of 2025 Q4 — sorted by position size